AlloSource Scientists Contribute to NASA’s Jet Propulsion Laboratory Study on Antimicrobial Survivability on the International Space Station
Centennial, Colo. — December 10, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, served as a contributing science team to NASA’s Jet Propulsion Laboratory’s (JPL) scientific study on further antimicrobial survivability on…
December 10, 2018Press ReleasesEnterobacter bugandesis,NASA,microbial
AlloSource Co-Authors International Space Station Microbial Study with NASA’s Jet Propulsion Laboratory
Centennial, Colo. — January 16, 2018 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts, and NASA’s Jet Propulsion Laboratory (JPL) co-authored a scientific publication titled “Detection of antimicrobial resistance genes associated with…
January 16, 2018Press ReleasesNASA,Technology,AlloSource,Microbiology
AlloSource Supports NASA And Jet Propulsion Laboratory On Microbial Study
Centennial, CO — August 25, 2016 — AlloSource, one of the nation’s largest providers of skin, bone and soft tissue allografts for use in surgical procedures and the world’s largest processor of cellular bone allografts, worked with NASA and the Jet Propulsion Laboratory (JPL) on microbial research…
August 25, 2016Press ReleasesInternational Space Station,NASA,AlloSource,microbes,zero gravity